TODAY'S MARKET INTELLIGENCE
ST Renfu: RFUS-188 Injection Enters Phase II Clinical Trial
English summary
ST Renfu announced that its RFUS-188 injection has entered Phase II clinical trials, a milestone in development. The progression could boost expectations, though clinical outcomes remain uncertain.
The English text is machine translated and may require verification against the Chinese version.
Browse today's intelligence